{"id":118558,"date":"2021-06-28T02:55:00","date_gmt":"2021-06-28T02:55:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=28855582885558"},"modified":"2021-06-28T02:55:00","modified_gmt":"2021-06-28T02:55:00","slug":"clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/","title":{"rendered":"Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics"},"content":{"rendered":"<p><strong><img decoding=\"async\" src=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/a2zmarketresearch\/Clinical%20Oncology%20Next-generation%20Sequencing%20Market%20Report%20.png?1624811125116\" alt=\"Clinical Oncology Next-generation Sequencing Market Report \" \/><\/strong><\/p>\n<p><a href=\"https:\/\/www.a2zmarketresearch.com\/data\/Global-Clinical-Oncology-Next-generation-Sequencing-Market-Report-2020---Growth,-Trend-and-Forecast-2027\/297510\"><strong>Clinical Oncology Next-generation Sequencing Market<\/strong>\u00a0<\/a>research report is the new statistical data source added by\u00a0<strong>A2Z Market Research<\/strong>. It uses several approaches for analyzing the data of target market such as primary and secondary research methodologies. It includes investigations based on historical records, current statistics, and futuristic developments.<\/p>\n<p><strong>Global Clinical Oncology Next-generation Sequencing Market size is expected to Expand at Significant CAGR of 13.2% during forecast period (2021-2027).<\/strong><\/p>\n<p>Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy.<\/p>\n<p><strong>Get Sample PDF Copy (Including FULL TOC, Graphs and Tables) of this report @:<\/strong><\/p>\n<p><a href=\"https:\/\/www.a2zmarketresearch.com\/sample?reportId=297510\"><strong>https:\/\/www.a2zmarketresearch.com\/sample?reportId=297510<\/strong><\/a><\/p>\n<p><strong>Top Key Players Profiled in this report are:\u00a0<\/strong><\/p>\n<p>GATC Biotech Ag, Oxford Nanopore Technologies Ltd., Macrogen Inc., Life technologies Corp., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics, Biomatters Ltd., BGI (Beijing Genomics Institute), Qiagen NV, Perkin Elmer, Inc., Pacific Bioscience, Inc., Partek, Inc., Bio-Rad Laboratories, Inc.<\/p>\n<p><strong>Global Clinical Oncology Next-generation Sequencing Market Segmentation:<\/strong><\/p>\n<p><strong>Market Segmentation by Product &#038; Services:<\/strong><\/p>\n<ul>\n<li>Sequencing platform<\/li>\n<li>Kits &#038; Reagents<\/li>\n<\/ul>\n<p><strong>Market Segmentation by Technology:<\/strong><\/p>\n<ul>\n<li>Whole Genome Sequencing<\/li>\n<li>Whole Exome Sequencing<\/li>\n<li>Targeted Sequencing &#038; Resequencing<\/li>\n<\/ul>\n<p><strong>Market Segmentation by Application:<\/strong><\/p>\n<ul>\n<li>Screening<\/li>\n<li>Companion Diagnostics<\/li>\n<li>Other Diagnostics<\/li>\n<\/ul>\n<p><strong>Market Segmentation by End-user:<\/strong><\/p>\n<ul>\n<li>Hospital Laboratories<\/li>\n<li>Clinical Research Organization<\/li>\n<li>Pharma &#038; Biotech Companies<\/li>\n<li>Diagnostic Laboratories<\/li>\n<li>Others<\/li>\n<\/ul>\n<p>\u00a0<\/p>\n<p><strong>The key questions answered in this report:<\/strong><\/p>\n<ul>\n<li>What will be the Market Size and Growth Rate in the forecast year?<\/li>\n<li>What are the Key Factors driving Clinical Oncology Next-generation Sequencing Market?<\/li>\n<li>What are the Risks and Challenges in front of the market?<\/li>\n<li>Who are the Key Vendors in Clinical Oncology Next-generation Sequencing Market?<\/li>\n<li>What are the Trending Factors influencing the market shares?<\/li>\n<li>What are the Key Outcomes of Porter\u2019s five forces model?<\/li>\n<li>Which are the Global Opportunities for Expanding the Clinical Oncology Next-generation Sequencing Market?<\/li>\n<\/ul>\n<p>\u00a0<\/p>\n<p>Various factors are responsible for the market\u2019s growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Clinical Oncology Next-generation Sequencing market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Clinical Oncology Next-generation Sequencing market\u2019s trajectory between forecast periods.<\/p>\n<p>\u00a0<\/p>\n<p><strong>Get up to 30% Discount on this Premium Report @:\u00a0<\/strong><\/p>\n<p><a href=\"https:\/\/www.a2zmarketresearch.com\/discount?reportId=297510\"><strong>https:\/\/www.a2zmarketresearch.com\/discount?reportId=297510<\/strong><\/a><\/p>\n<p>The cost analysis of the Global Clinical Oncology Next-generation Sequencing Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.<\/p>\n<p><strong>The report provides insights on the following pointers:<\/strong><\/p>\n<p><strong>Market Penetration:<\/strong>\u00a0Comprehensive information on the product portfolios of the top players in the Clinical Oncology Next-generation Sequencing market.<\/p>\n<p><strong>Product Development\/Innovation:<\/strong>\u00a0Detailed insights on the upcoming technologies, R&#038;D activities, and product launches in the market.<\/p>\n<p><strong>Competitive Assessment<\/strong>: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.<\/p>\n<p><strong>Market Development:<\/strong>\u00a0Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.<\/p>\n<p><strong>Market Diversification:\u00a0<\/strong>Exhaustive information about new products, untapped geographies, recent developments, and investments in the Clinical Oncology Next-generation Sequencing market.<\/p>\n<p>\u00a0<\/p>\n<p><strong>Table of Contents<\/strong><\/p>\n<p><strong>Global Clinical Oncology Next-generation Sequencing Market Research Report 2021 \u2013 2027<\/strong><\/p>\n<p>Chapter 1 Clinical Oncology Next-generation Sequencing Market Overview<\/p>\n<p>Chapter 2 Global Economic Impact on Industry<\/p>\n<p>Chapter 3 Global Market Competition by Manufacturers<\/p>\n<p>Chapter 4 Global Production, Revenue (Value) by Region<\/p>\n<p>Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions<\/p>\n<p>Chapter 6 Global Production, Revenue (Value), Price Trend by Type<\/p>\n<p>Chapter 7 Global Market Analysis by Application<\/p>\n<p>Chapter 8 Manufacturing Cost Analysis<\/p>\n<p>Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers<\/p>\n<p>Chapter 10 Marketing Strategy Analysis, Distributors\/Traders<\/p>\n<p>Chapter 11 Market Effect Factors Analysis<\/p>\n<p>Chapter 12 Global Clinical Oncology Next-generation Sequencing Market Forecast<\/p>\n<p><strong>Buy Exclusive Report @:<\/strong><\/p>\n<p><a href=\"https:\/\/www.a2zmarketresearch.com\/buy?reportId=297510\"><strong>https:\/\/www.a2zmarketresearch.com\/buy?reportId=297510<\/strong><\/a><\/p>\n<p><strong>If you have any special requirements, please let us know and we will offer you the report as you want.\u00a0\u00a0\u00a0<\/strong><\/p>\n<p><strong>About A2Z Market Research:<\/strong><\/p>\n<p>The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.<\/p>\n<p>Our Research Analyst Provides business insights and market research reports for large and small businesses.<\/p>\n<p>The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F &#038; B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.<\/p>\n<p><strong>Contact Us:<\/strong><\/p>\n<p>Roger Smith<\/p>\n<p>1887 WHITNEY MESA DR HENDERSON, NV 89014<\/p>\n<p><a href=\"mailto:sales@a2zmarketresearch.com\">sales@a2zmarketresearch.com<\/a><\/p>\n<p>+1 775 237 4147<\/p>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Contact Us: Roger Smith, 1887 WHITNEY MESA DR HENDERSON, NV 89014, sales@a2zmarketresearch.com, +1 775 237 4147<\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/\">Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Clinical Oncology Next-generation Sequencing Market&nbsp;research report is the new statistical data source added by&nbsp;A2Z Market Research. It uses several approaches for analyzing the data of target market such as primary and secondary research methodologies. It includes investigations based on historical records, current statistics, and futuristic developments. Global Clinical Oncology Next-generation Sequencing Market size is expected [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/\">Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-118558","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics - Business\" \/>\n<meta property=\"og:description\" content=\"Clinical Oncology Next-generation Sequencing Market&nbsp;research report is the new statistical data source added by&nbsp;A2Z Market Research. It uses several approaches for analyzing the data of target market such as primary and secondary research methodologies. It includes investigations based on historical records, current statistics, and futuristic developments. Global Clinical Oncology Next-generation Sequencing Market size is expected [&hellip;] The post Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-28T02:55:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/a2zmarketresearch\/Clinical%20Oncology%20Next-generation%20Sequencing%20Market%20Report%20.png?1624811125116\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/\",\"url\":\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/\",\"name\":\"Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/a2zmarketresearch\/Clinical%20Oncology%20Next-generation%20Sequencing%20Market%20Report%20.png?1624811125116\",\"datePublished\":\"2021-06-28T02:55:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/#primaryimage\",\"url\":\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/a2zmarketresearch\/Clinical%20Oncology%20Next-generation%20Sequencing%20Market%20Report%20.png?1624811125116\",\"contentUrl\":\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/a2zmarketresearch\/Clinical%20Oncology%20Next-generation%20Sequencing%20Market%20Report%20.png?1624811125116\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics - Business","og_description":"Clinical Oncology Next-generation Sequencing Market&nbsp;research report is the new statistical data source added by&nbsp;A2Z Market Research. It uses several approaches for analyzing the data of target market such as primary and secondary research methodologies. It includes investigations based on historical records, current statistics, and futuristic developments. Global Clinical Oncology Next-generation Sequencing Market size is expected [&hellip;] The post Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/","og_site_name":"Business","article_published_time":"2021-06-28T02:55:00+00:00","og_image":[{"url":"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/a2zmarketresearch\/Clinical%20Oncology%20Next-generation%20Sequencing%20Market%20Report%20.png?1624811125116","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/","url":"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/","name":"Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/#primaryimage"},"image":{"@id":"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/a2zmarketresearch\/Clinical%20Oncology%20Next-generation%20Sequencing%20Market%20Report%20.png?1624811125116","datePublished":"2021-06-28T02:55:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/#primaryimage","url":"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/a2zmarketresearch\/Clinical%20Oncology%20Next-generation%20Sequencing%20Market%20Report%20.png?1624811125116","contentUrl":"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/a2zmarketresearch\/Clinical%20Oncology%20Next-generation%20Sequencing%20Market%20Report%20.png?1624811125116"},{"@type":"BreadcrumbList","@id":"http:\/\/ipsnews.net\/business\/2021\/06\/28\/clinical-oncology-next-generation-sequencing-market-to-witness-robust-expansion-by-2027-gatc-biotech-ag-oxford-nanopore-technologies-ltd-dnastar-inc-myriad-genetics-exosome-diagnostics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Clinical Oncology Next-generation Sequencing Market to Witness Robust Expansion by 2027 | GATC Biotech Ag, Oxford Nanopore Technologies Ltd., DNASTAR Inc., Myriad Genetics, Exosome Diagnostics"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/118558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=118558"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/118558\/revisions"}],"predecessor-version":[{"id":118559,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/118558\/revisions\/118559"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=118558"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=118558"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=118558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}